4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0000885590-15-000047
$BHCCIK 0000885590operating
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:45 PM ET
Size
16.3 KB
Accession
0000885590-15-000047
Insider Transaction Report
Form 4
Mirovsky Pavel
President of Valeant Europe
Transactions
- Exercise/Conversion
Common Stock, no par value
2015-06-01$51.01/sh+100$5,101→ 36,775 total - Exercise/Conversion
Common Stock, no par value
2015-06-02$51.01/sh+14,900$760,049→ 51,575 total - Sale
Common Stock, no par value
2015-06-02$237.94/sh−14,900$3,545,306→ 36,675 total - Exercise/Conversion
Non-Qualified Stock Options (right to purchase)
2015-06-01−100→ 19,900 totalExercise: $51.01From: 2016-05-15Exp: 2022-05-15→ Common shares, no par value (100 underlying) - Sale
Common Stock, no par value
2015-06-01$240.00/sh−100$24,000→ 36,675 total - Sale
Common Stock, no par value
2015-06-02$238.04/sh−23,000$5,475,012→ 13,675 total - Exercise/Conversion
Non-Qualified Stock Options (right to purchase)
2015-06-02−14,900→ 5,000 totalExercise: $51.01From: 2016-05-15Exp: 2022-05-15→ Common shares, no par value (14,900 underlying)
Footnotes (3)
- [F1]This number represents the weighted average sale price for all sales of common stock acquired upon exercise of options and sold. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
- [F2]This number represents the weighted average sale price for all sales of common stock previously held that were sold. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
- [F3]The options vested one-fourth per year over four years starting with the first vest date falling on the first anniversary of the equity grant date, the second vest date falling on the second anniversary of the equity grant date, the third vest date falling on the third anniversary of the equity grant date, and the fourth vest date falling on the fourth anniversary of the equity grant date.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 5:45 PM ET
- Size
- 16.3 KB